{"id":8195,"date":"2025-04-03T16:27:46","date_gmt":"2025-04-03T08:27:46","guid":{"rendered":"https:\/\/regask.com\/?p=8195"},"modified":"2025-04-03T16:27:46","modified_gmt":"2025-04-03T08:27:46","slug":"regask-est-presente-dans-bloomberg-trump-pharma-menace-de-tarifs-douaniers","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\/","title":{"rendered":"RegASK pr\u00e9sent\u00e9 dans Bloomberg\u00a0: les menaces de Trump contre l&#039;industrie pharmaceutique\u2026"},"content":{"rendered":"<p class=\"\" data-start=\"205\" data-end=\"483\"><a href=\"https:\/\/www.bloomberg.com\/news\/articles\/2025-04-01\/trump-tariffs-pharmaceutical-industry-levies-threaten-major-disruption?accessToken=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzb3VyY2UiOiJTdWJzY3JpYmVyR2lmdGVkQXJ0aWNsZSIsImlhdCI6MTc0MzUxMzMyNCwiZXhwIjoxNzQ0MTE4MTI0LCJhcnRpY2xlSWQiOiJTVFpXUk1UMEFGQjQwMCIsImJjb25uZWN0SWQiOiIzM0I0MEFBODBFRkM0OEIyOEJCQUM4MEQyNzFENENDMiJ9.k4P1PIivL0WpdbDZCkeHUouIDNXRGpnp4RPZLxse1BI&amp;leadSource=uverify%20wall\">Bloomberg<\/a> r\u00e9cemment mis en \u00e9vidence <a href=\"https:\/\/regask.com\/fr\/\">RegASK<\/a> Aper\u00e7u des d\u00e9fis croissants auxquels sont confront\u00e9es les entreprises pharmaceutiques face aux nouveaux tarifs douaniers am\u00e9ricains. Cet article met en lumi\u00e8re la mani\u00e8re dont les fabricants de m\u00e9dicaments r\u00e9agissent en augmentant leurs stocks et en explorant des strat\u00e9gies alternatives pour leur cha\u00eene d&#039;approvisionnement.<\/p>\n<p class=\"\" data-start=\"461\" data-end=\"551\">Caroline Shleifer, PDG de RegASK, a expliqu\u00e9 comment les entreprises s&#039;adaptent \u00e0 l&#039;incertitude :<\/p>\n<p class=\"\" data-start=\"553\" data-end=\"777\"><em data-start=\"553\" data-end=\"775\">\u00ab La plupart des entreprises qui ont des m\u00e9dicaments ayant une dur\u00e9e de conservation suffisante souhaitent disposer d&#039;au moins trois \u00e0 six mois de stock aux \u00c9tats-Unis, le temps de r\u00e9\u00e9valuer l&#039;impact potentiel et de trouver des solutions de contournement potentielles aux droits de douane. \u00bb<\/em><\/p>\n<p class=\"\" data-start=\"779\" data-end=\"979\">Alors que les entreprises pharmaceutiques augmentent leurs exp\u00e9ditions de fret a\u00e9rien et explorent des solutions r\u00e9glementaires, RegASK fournit des renseignements bas\u00e9s sur l&#039;IA pour aider les entreprises \u00e0 naviguer dans l&#039;\u00e9volution des politiques commerciales.<\/p>\n<p class=\"\" data-start=\"1037\" data-end=\"1094\">Lire l&#039;article complet de Bloomberg <a href=\"https:\/\/www.bloomberg.com\/news\/articles\/2025-04-01\/trump-tariffs-pharmaceutical-industry-levies-threaten-major-disruption?accessToken=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzb3VyY2UiOiJTdWJzY3JpYmVyR2lmdGVkQXJ0aWNsZSIsImlhdCI6MTc0MzUxMzMyNCwiZXhwIjoxNzQ0MTE4MTI0LCJhcnRpY2xlSWQiOiJTVFpXUk1UMEFGQjQwMCIsImJjb25uZWN0SWQiOiIzM0I0MEFBODBFRkM0OEIyOEJCQUM4MEQyNzFENENDMiJ9.k4P1PIivL0WpdbDZCkeHUouIDNXRGpnp4RPZLxse1BI&amp;leadSource=uverify%20wall\">ici<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Bloomberg a r\u00e9cemment mis en lumi\u00e8re l&#039;analyse de RegASK concernant les difficult\u00e9s croissantes rencontr\u00e9es par les entreprises pharmaceutiques en raison des nouveaux droits de douane am\u00e9ricains. L&#039;article souligne comment les fabricants de m\u00e9dicaments r\u00e9agissent en augmentant leurs stocks et en explorant des strat\u00e9gies alternatives pour leur cha\u00eene d&#039;approvisionnement. Caroline Shleifer, PDG de RegASK, a expliqu\u00e9 comment les entreprises s&#039;adaptent \u00e0 cette incertitude\u00a0: \u201c\u00a0La plupart des entreprises qui disposent de m\u00e9dicaments avec une dur\u00e9e de conservation suffisante\u2026<\/p>","protected":false},"author":22,"featured_media":8196,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[528],"tags":[],"class_list":["post-8195","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>RegASK Featured in Bloomberg: Trump\u2019s Pharma Threats Take Tariffs Into Uncharted Territory | RegASK<\/title>\n<meta name=\"description\" content=\"Bloomberg features RegASK CEO Caroline Shleifer\u2019s insights on how Trump\u2019s tariffs impact pharmaceutical supply chains.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/regask-est-presente-dans-bloomberg-trump-pharma-menace-de-tarifs-douaniers\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RegASK Featured in Bloomberg: Trump\u2019s Pharma Threats Take Tariffs Into Uncharted Territory\" \/>\n<meta property=\"og:description\" content=\"Bloomberg features RegASK CEO Caroline Shleifer\u2019s insights on how Trump\u2019s tariffs impact pharmaceutical supply chains.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/regask-est-presente-dans-bloomberg-trump-pharma-menace-de-tarifs-douaniers\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-03T08:27:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-bloomberg.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Divvya Behal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Divvya Behal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\\\/\"},\"author\":{\"name\":\"Divvya Behal\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\"},\"headline\":\"RegASK Featured in Bloomberg: Trump\u2019s Pharma Threats &hellip;\",\"datePublished\":\"2025-04-03T08:27:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\\\/\"},\"wordCount\":129,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-bloomberg.jpg\",\"articleSection\":[\"Company News\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\\\/\",\"name\":\"RegASK Featured in Bloomberg: Trump\u2019s Pharma Threats Take Tariffs Into Uncharted Territory | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-bloomberg.jpg\",\"datePublished\":\"2025-04-03T08:27:46+00:00\",\"description\":\"Bloomberg features RegASK CEO Caroline Shleifer\u2019s insights on how Trump\u2019s tariffs impact pharmaceutical supply chains.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-bloomberg.jpg\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-bloomberg.jpg\",\"width\":1200,\"height\":900,\"caption\":\"Regask Featured Bloomberg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\",\"name\":\"Divvya Behal\",\"sameAs\":[\"https:\\\/\\\/regask.com\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"RegASK \u00e0 l&#039;honneur dans Bloomberg\u00a0: les menaces de Trump contre l&#039;industrie pharmaceutique propulsent les tarifs douaniers vers des territoires inconnus | RegASK","description":"Bloomberg pr\u00e9sente les r\u00e9flexions de Caroline Shleifer, PDG de RegASK, sur l&#039;impact des tarifs douaniers de Trump sur les cha\u00eenes d&#039;approvisionnement pharmaceutiques.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/regask-est-presente-dans-bloomberg-trump-pharma-menace-de-tarifs-douaniers\/","og_locale":"fr_FR","og_type":"article","og_title":"RegASK Featured in Bloomberg: Trump\u2019s Pharma Threats Take Tariffs Into Uncharted Territory","og_description":"Bloomberg features RegASK CEO Caroline Shleifer\u2019s insights on how Trump\u2019s tariffs impact pharmaceutical supply chains.","og_url":"https:\/\/regask.com\/fr\/regask-est-presente-dans-bloomberg-trump-pharma-menace-de-tarifs-douaniers\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2025-04-03T08:27:46+00:00","og_image":[{"width":1200,"height":900,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-bloomberg.jpg","type":"image\/jpeg"}],"author":"Divvya Behal","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Divvya Behal","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\/#article","isPartOf":{"@id":"https:\/\/regask.com\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\/"},"author":{"name":"Divvya Behal","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0"},"headline":"RegASK Featured in Bloomberg: Trump\u2019s Pharma Threats &hellip;","datePublished":"2025-04-03T08:27:46+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\/"},"wordCount":129,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-bloomberg.jpg","articleSection":["Company News"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\/","url":"https:\/\/regask.com\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\/","name":"RegASK \u00e0 l&#039;honneur dans Bloomberg\u00a0: les menaces de Trump contre l&#039;industrie pharmaceutique propulsent les tarifs douaniers vers des territoires inconnus | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-bloomberg.jpg","datePublished":"2025-04-03T08:27:46+00:00","description":"Bloomberg pr\u00e9sente les r\u00e9flexions de Caroline Shleifer, PDG de RegASK, sur l&#039;impact des tarifs douaniers de Trump sur les cha\u00eenes d&#039;approvisionnement pharmaceutiques.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/regask-featured-in-bloomberg-trump-pharma-threats-tariffs\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-bloomberg.jpg","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-bloomberg.jpg","width":1200,"height":900,"caption":"Regask Featured Bloomberg"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Le syst\u00e8me d&#039;exploitation d&#039;IA r\u00e9glementaire pour les \u00e9quipes performantes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0","name":"Divvya Behal","sameAs":["https:\/\/regask.com"]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/8195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=8195"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/8195\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/8196"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=8195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=8195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=8195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}